Genentech Releases SMA Community Letter

Genentech, a member of the Roche Group, logo

Our industry partners at Genentech recently released an SMA community letter summarizing 2022 developments and initiates. Check it out here!

Do you like what you're reading?

Help make a difference in the lives of people affected by spinal muscular atrophy.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top